A paradigm shift in cellularbased therapy for regenerative medicine|Karolis Rosickas,Chief Executive Officer,Regeneus 00:10:00

Share On Facebook Share On Twitter

Karolis was appointed CEO of Regeneus on 2 November 2020. Karolis is an experienced executive and healthcare entrepreneur with over 15 years' business experience in healthcare, technology and finance, including in global businesses. He was most recently CEO and co- founder of OME Health, a nutrition technology business, and co-founded SingCell, a stem cell contract development and manufacturing organisation in Sintapore. Karolis has also held senior positions at HSBC, JP Morgan, Danone, Santander Group and KPMG in his career. He holds an MBA from IESE Business School and is CFA qualified.

Recent Videos